Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids
Open Access
- 2 August 2011
- journal article
- review article
- Published by Hindawi Limited in International Journal of Rheumatology
- Vol. 2011, 1-17
- https://doi.org/10.1155/2011/969012
Abstract
Osteoarthritis (OA) is a degenerative joint disease that is characterized by increasing loss of cartilage, remodeling of the periarticular bone, and inflammation of the synovial membrane. Besides the common OA therapy with nonsteroidal anti-inflammatory drugs (NSAIDs), the treatment with chondroprotectives, such as glucosamine sulfate, chondroitin sulfate, hyaluronic acid, collagen hydrolysate, or nutrients, such as antioxidants and omega-3 fatty acids is a promising therapeutic approach. Numerous clinical studies have demonstrated that the targeted administration of selected micronutrients leads to a more effective reduction of OA symptoms, with less adverse events. Their chondroprotective action can be explained by a dual mechanism: (1) as basic components of cartilage and synovial fluid, they stimulate the anabolic process of the cartilage metabolism; (2) their anti-inflammatory action can delay many inflammation-induced catabolic processes in the cartilage. These two mechanisms are able to slow the progression of cartilage destruction and may help to regenerate the joint structure, leading to reduced pain and increased mobility of the affected joint.Keywords
This publication has 139 references indexed in Scilit:
- The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combinationOsteoarthritis and Cartilage, 2010
- Mitochondrial Dysregulation of Osteoarthritic Human Articular Chondrocytes Analyzed by ProteomicsMolecular & Cellular Proteomics, 2009
- The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trialArthritis & Rheumatism, 2008
- Obesity and Osteoarthritis: Disease Genesis and Nonpharmacologic Weight ManagementRheumatic Disease Clinics of North America, 2008
- Genome-wide Association Scan Identifies a Prostaglandin-Endoperoxide Synthase 2 Variant Involved in Risk of Knee OsteoarthritisAmerican Journal of Human Genetics, 2008
- Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritisBritish Journal of Pharmacology, 2008
- OsteoarthritisJournal of Cellular Physiology, 2007
- Glucosamine therapy for treating osteoarthritisEmergencias, 2005
- Knee Structural Alteration and BMI: A Cross‐sectional StudyObesity Research, 2005
- Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?Arthritis & Rheumatism, 1996